4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-24-000083
EVP Strategy and Corporate Dev sold 2,423 shares at $126.58 ($306,703)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dolan Matthew Vincent EVP Strategy and Corporate Dev | 2024-05-15 | Sale 10b5-1 | −2,423 | $126.58 | $306,703 | 40,075 | D: show line 1 in the form |
| Open-market sales · 2,423 sh · avg $126.58 · $306,703 | |||||||
Loading xslF345X05/edgardoc.xml…